383 related articles for article (PubMed ID: 11082294)
21. Regulation of protein kinase C-delta and -epsilon isoforms by phorbol ester treatment of LLC-PK1 renal epithelia.
Clarke H; Ginanni N; Soler AP; Mullin JM
Kidney Int; 2000 Sep; 58(3):1004-15. PubMed ID: 10972665
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
23. Proteasome implication in phorbol ester- and GnRH-induced selective down-regulation of PKC (alpha, epsilon, zeta) in alpha T(3)-1 and L beta T(2) gonadotrope cell lines.
Junoy B; Maccario H; Mas JL; Enjalbert A; Drouva SV
Endocrinology; 2002 Apr; 143(4):1386-403. PubMed ID: 11897696
[TBL] [Abstract][Full Text] [Related]
24. Bryostatins selectively regulate protein kinase C-mediated effects on GH4 cell proliferation.
Mackanos EA; Pettit GR; Ramsdell JS
J Biol Chem; 1991 Jun; 266(17):11205-12. PubMed ID: 1904062
[TBL] [Abstract][Full Text] [Related]
25. Bryostatin-1 attenuates TNF-induced epithelial barrier dysfunction: role of novel PKC isozymes.
Yoo J; Nichols A; Song JC; Mammen J; Calvo I; Worrell RT; Cuppoletti J; Matlin K; Matthews JB
Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G703-12. PubMed ID: 12505880
[TBL] [Abstract][Full Text] [Related]
26. Modulation by staurosporine of phorbol-ester-induced effects on growth and protein kinase C localization in A549 human lung-carcinoma cells.
Bradshaw TD; Gescher A; Pettit GR
Int J Cancer; 1992 Apr; 51(1):144-8. PubMed ID: 1563835
[TBL] [Abstract][Full Text] [Related]
27. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
Scala S; Dickstein B; Regis J; Szallasi Z; Blumberg PM; Bates SE
Clin Cancer Res; 1995 Dec; 1(12):1581-7. PubMed ID: 9815959
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase C-alpha and -epsilon down-regulate cell surface sodium channels via differential mechanisms in adrenal chromaffin cells.
Yanagita T; Kobayashi H; Yamamoto R; Kataoka H; Yokoo H; Shiraishi S; Minami S; Koono M; Wada A
J Neurochem; 2000 Apr; 74(4):1674-84. PubMed ID: 10737626
[TBL] [Abstract][Full Text] [Related]
29. Dephosphorylation of activated protein kinase C contributes to downregulation by bryostatin.
Lee HW; Smith L; Pettit GR; Bingham Smith J
Am J Physiol; 1996 Jul; 271(1 Pt 1):C304-11. PubMed ID: 8760059
[TBL] [Abstract][Full Text] [Related]
30. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
Levine BL; May WS; Tyler PG; Hess AD
J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742
[TBL] [Abstract][Full Text] [Related]
31. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE
Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938
[TBL] [Abstract][Full Text] [Related]
32. The protein kinase C inhibitor, bisindolylmaleimide, inhibits the TPA-induced but not the TNF-induced increase in LLC-PK1 transepithelial permeability.
Marano CW; Laughlin KV; Russo LM; Mullin JM
Biochem Biophys Res Commun; 1995 Apr; 209(2):669-76. PubMed ID: 7733936
[TBL] [Abstract][Full Text] [Related]
33. Increased tight junction permeability can result from protein kinase C activation/translocation and act as a tumor promotional event in epithelial cancers.
Mullin JM; Laughlin KV; Ginanni N; Marano CW; Clarke HM; Peralta Soler A
Ann N Y Acad Sci; 2000; 915():231-6. PubMed ID: 11193580
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of membrane lipid-independent protein kinase Calpha activity by phorbol esters, diacylglycerols, and bryostatin-1.
Slater SJ; Taddeo FJ; Mazurek A; Stagliano BA; Milano SK; Kelly MB; Ho C; Stubbs CD
J Biol Chem; 1998 Sep; 273(36):23160-8. PubMed ID: 9722545
[TBL] [Abstract][Full Text] [Related]
35. Ubiquitination of protein kinase C-alpha and degradation by the proteasome.
Lee HW; Smith L; Pettit GR; Vinitsky A; Smith JB
J Biol Chem; 1996 Aug; 271(35):20973-6. PubMed ID: 8702857
[TBL] [Abstract][Full Text] [Related]
36. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.
Basu A; Lazo JS
Cancer Res; 1992 Jun; 52(11):3119-24. PubMed ID: 1591725
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase C-alpha activity modulates transepithelial permeability and cell junctions in the LLC-PK1 epithelial cell line.
Rosson D; O'Brien TG; Kampherstein JA; Szallasi Z; Bogi K; Blumberg PM; Mullin JM
J Biol Chem; 1997 Jun; 272(23):14950-3. PubMed ID: 9169467
[TBL] [Abstract][Full Text] [Related]
38. Effects of bryostatin 1, a novel anticancer agent, on intestinal transport and barrier function: role of protein kinase C.
Farokhzad OC; Mun EC; Sicklick JK; Smith JA; Matthews JB
Surgery; 1998 Aug; 124(2):380-6; discussion 386-7. PubMed ID: 9706162
[TBL] [Abstract][Full Text] [Related]
39. Protein kinase C activation without membrane contact in platelets stimulated by bryostatin.
Grabarek J; Ware JA
J Biol Chem; 1993 Mar; 268(8):5543-9. PubMed ID: 8449916
[TBL] [Abstract][Full Text] [Related]
40. 12-O-tetradecanoylphorbol-13-acetate induces apoptosis in renal epithelial cells through a growth signal conflict which is prevented by activated ras.
Lee RG; Rosson D
Arch Biochem Biophys; 2001 Jan; 385(2):378-86. PubMed ID: 11368020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
